CVS

CVS AI Signal Analysis

Multi-agent conviction signals powered by SEC filings, insider trades, institutional holdings, and earnings data

1signals

avg conviction+22

1/0

Mar 28, 2026

conviction

Bullish(low)

CVS has delivered four consecutive earnings beats with the most recent quarter coming in 8.8% above consensus, and gross profit grew 3.6% YoY to $21.4B with clean forensic accounting — a solid but not accelerating fundamental picture. Options flow shows a striking 44:1 dollar-weighted bullish imbalance ($3.2M in bullish sweeps vs. $72.8K bearish) with 18 unusual call contracts flagged, suggesting near-term institutional positioning for upside. However, the Administrative Simplification rule and wage protection regulation introduce real cost headwinds for Aetna and CVS's retail workforce without a revenue offset, and elevated implied volatility relative to historical volatility (ratio of 1.63) alongside a 2.11% put-skew signal the market is simultaneously hedging meaningful downside. The setup warrants a small, time-limited bullish position driven primarily by options flow, with tight risk management given regulatory and cost pressures.

+21

+22

Agent Breakdown

Fundamentals AgentBullish

+12

CVS shows consistent earnings beats (4/4 quarters, most recent 8.8% above consensus) and gross profit growth of 3.6% YoY to $21.4B, with clean forensic accounting; however, the QoQ gross profit surge of 52.1% warrants scrutiny for seasonality or one-time items, and stable beat cadence alone does not justify strong bullishness without evidence of accelerating fundamentals.

Sources

ForensicForensic score: 100/100 (0 flags)
EarningsEPS beat: $1.09 vs $1.00 est (+8.8%)
Analyst RatingAnalyst consensus: 7 strong buy, 18 buy, 8 hold, 0 sell, 0 strong sell

Policy AgentNeutral

-5

The Mar 24 Administrative Simplification rule (importance=100) mandating new health care claims attachment standards will require CVS Health and its Aetna/PBM segments to invest in IT and compliance infrastructure, creating near-term cost headwinds without revenue offset. The wage protection regulation (Mar 27, importance=85) adds incremental labor cost pressure across CVS's large retail and pharmacy workforce.

Sources

Options AgentBullish

+52

Aggressive bullish sweep activity dominates the 48-hour flow with $3.2M in bullish sweeps versus only $72.8K bearish, a 44:1 dollar-weighted imbalance, while the call/put volume ratio of 0.43 (30,358 calls vs 13,082 puts) and 18 unusual call contracts versus 7 put contracts confirm directional call accumulation; however, elevated IV/HV ratio of 1.63 and a 2.11% put-skew indicate the market is simultaneously pricing meaningful downside risk, tempering conviction.

Sources

IV DataIV metrics: 55.6% percentile, IV/HV ratio 1.63

Unlock agent-level analysis

See exactly what each AI agent found — forensic accounting flags, insider clusters, institutional shifts, and more.

Get started View pricing

Trade Plan

Live Return

$70.08-1.5%

Entry: $71.18 · 0d elapsed / 30d horizon

Tracking

Entry Zone

In entry zone

$70.00

$72.00

Valid until Apr 7, 2026

Price Targets (30-day)

Bull

$79.50+13.4%

Re-rating toward 52-week range upper bound if Q1 earnings beat sustains and regulatory concerns are priced in ahead of results

Base

$75.50+7.7%

Modest recovery to fair value reflecting stable earnings cadence and options flow momentum fading within 30 days

Bear

$67.00-4.4%

Breakdown below recent support if regulatory cost guidance disappoints or gross profit normalization is confirmed

Stop Loss

$67.50

-3.7%

Position Size

1-2%

of portfolio

Risk/Reward

1.9x

base target

Unlock the trade plan

Get entry zones, price targets, stop loss levels, and position sizing for every signal.

Get started View pricing

Get the full picture on CVS

Our AI analyst team runs 5 specialized agents on every stock. Unlock detailed breakdowns, trade plans, and real-time alerts.

Start for $9/mo View pricing

Not financial advice. For informational purposes only. Past performance does not guarantee future results.